Federated Hermes’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-388
Closed -$16K 2323
2020
Q3
$16K Buy
388
+82
+27% +$3.6K ﹤0.01% 1923
2020
Q2
$13K Sell
306
-21
-6% -$795 ﹤0.01% 1913
2020
Q1
$11K Buy
327
+19
+6% +$686 ﹤0.01% 1862
2019
Q4
$13K Buy
+308
New +$13K ﹤0.01% 1883
2019
Q2
Sell
-65,109
Closed -$2.83M 2213
2019
Q1
$2.83M Sell
65,109
-2
-0% -$102 0.01% 936
2018
Q4
$3.08M Sell
65,111
-50,886
-44% -$3.05M 0.01% 878
2018
Q3
$8.66M Buy
115,997
+44,275
+62% +$3.05M 0.02% 622
2018
Q2
$3.96M Buy
+71,722
New +$3.31M 0.01% 760
2016
Q3
Sell
-242
Closed -$6K 2165
2016
Q2
$6K Buy
+242
New +$5.3K ﹤0.01% 1877
2015
Q3
Sell
-249
Closed -$6K 2036
2015
Q2
$6K Sell
249
-137
-35% -$3.44K ﹤0.01% 1777
2015
Q1
$10K Buy
+386
New +$9.19K ﹤0.01% 1782

Other funds holding SRDX

Federated Hermes's SRDX Position: Q4 2020 in Review

Federated Hermes sold out of Surmodics (SRDX) in Q4 2020, closing a stake of 388 shares — an estimated $16K sold.

Federated Hermes first reported a position in SRDX in Q1 2015 and held it in 11 quarters. The position peaked at $8.66M in Q3 2018. 140 funds tracked by Wall St. Rank hold SRDX as of Q4 2020.

  • Federated Hermes reported no remaining Surmodics position as of Q4 2020 after selling out during the quarter.
  • Federated Hermes sold 388 Surmodics shares in Q4 2020, an estimated $16K.
  • Federated Hermes first reported a position in Surmodics in Q1 2015 and held it in 11 quarters.
  • Federated Hermes's Surmodics position peaked at $8.66M in Q3 2018.
  • 140 funds tracked by Wall St. Rank held Surmodics as of Q4 2020.

Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.